0
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2011;305(17):1733. doi:10.1001/jama.2011.565.
Text Size: A A A
Published online
Figures in this Article

CORONARY REVASCULARIZATION TRENDS

To assess whether recent advances in technology, new clinical trial evidence, and updated clinical practice guidelines have influenced the volume and distribution of coronary revascularization procedures in the United States, Epstein and colleagues analyzed nationally representative hospital discharge data and assessed trends in the rates and types of coronary revascularization procedures performed from 2001 to 2008. The authors found that the annual rate of coronary revascularization decreased 15% between 2001 and 2008. During this time, the annual rate of coronary artery bypass grafting decreased substantially, but rates of percutaneous coronary interventions did not change significantly.

URINARY SODIUM EXCRETION AND HEALTH OUTCOMES

Extrapolations from observational studies and short-term intervention trials suggest that population-wide moderation of salt intake might reduce the cardiovascular event rate. However, whether individuals with lower salt intake have lower blood pressure and lower risks of cardiovascular events—in the long term—is not clear. In a prospective cohort study involving individuals who at baseline were normotensive and without cardiovascular disease, Stolarz-Skrzypek and colleagues examined the association of 24-hour urinary sodium excretion with cardiovascular morbidity and mortality. Participants were followed up for a median 7.9 years. Among the authors' findings were that lower sodium excretion was associated with higher cardiovascular mortality and the risk of hypertension did not increase across tertiles.

COMPARATIVE EFFICACY DATA AND DRUG APPROVAL

Comparative efficacy information on new drugs would be most useful shortly after marketing approval, when observational data from routine care and from head-to-head trials are not yet available. In a review of drug approval information for new molecular entities approved by the US Food and Drug Administration (FDA) between 2000 and 2010, Goldberg and colleagues assessed whether comparative efficacy data were available at the time of FDA approval. The authors report that comparative efficacy data were included in publicly available FDA approval materials for about half of all new molecular entities and for two-thirds of new molecular entities for which alternative treatment options existed.

CLINICIAN'S CORNER
EXERCISE TRAINING AND HBA1C IN TYPE 2 DIABETES

Umpierre and colleagues Article report results of a systematic review and meta-analysis of data from 47 randomized trials that examined the association of structured exercise training (aerobic, resistance, or both) or physical activity advice with reductions in hemoglobin A1c (HbA1c) in patients with type 2 diabetes. Among the authors' findings were that patients who received structured exercise training experienced greater reductions in HbA1c than control group patients, and exercise interventions that exceeded 150 minutes per week were associated with greater HbA1c decreases than exercise interventions of shorter weekly duration. Physical activity advice was associated with HbA1c reductions only when combined with dietary recommendations. In an editorial, Pahor Article discusses the cost-effectiveness of structured exercise programs, particularly for high-risk populations.

A PIECE OF MY MIND

“Balancing my personal life and my career was already a challenge. Why complicate things now?” From “It's Never Too Late.”

MEDICAL NEWS & PERSPECTIVES

Scientists are probing the effects of anesthetic agents on long-term outcomes in pediatric patients.

COMMENTARIES

Accountable care organizations and patient empowerment

Physician-patient communication

Conscience-based care refusals and quality medical care

What next for QALYs?

LITERATIM

John Harvey Kellogg and the pursuit of wellness

AUTHOR IN THE ROOM TELECONFERENCE

Join Lydia A. Bazzano, MD, PhD, Wednesday, May 18, from 2 to 3 PM eastern time to discuss antihypertensive treatment and cardiovascular disease (CVD) prevention for normotensive individuals with CVD. To register, go to http://www.ihi.org/AuthorintheRoom.

READERS RESPOND

A patient has a renal mass discovered with MRI that was not addressed clinically for several months. How would you improve physician communication? Go to www.jama.com to read the case. Submit your response by May 8 for possible online publication.

JAMA PATIENT PAGE

For your patients: Information about rheumatoid arthritis.

First Page Preview

View Large
First page PDF preview

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.